Abstract:Portal hypertension (PH) is the result of portal blood flow obstruction and/or increased blood flow caused by various reasons, and is also the direct cause of decompensation of cirrhosis, which can increase the mortality of patients in a short time. Therefore, early detection, early treatment and early monitoring of PH have great significance to improve the prognosis of patients and reduce the mortality. Noninvasive prediction model has the characteristics of safety, simplicity and economy, and has important value in PH evaluation, which is a research hotspot in recent years. In this review, six noninvasive prediction models, including liver function test score (Child-Pugh score), aspartate aminotransferase/platelet ratio index score (APRI score), integrated end-stage liver disease model score (iMELD score), enhanced liver fibrosis score, liver hardness spleen diameter/platelet count score (LSPS), von lebrand factor antigen/platelet count score (VITRO score), were reviewed for PH diagnosis and prognosis assessment of cirrhosis.